Skip to main content

Peer Review reports

From: Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors

Original Submission
8 Feb 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
31 Oct 2016 Editorially accepted
8 Nov 2016 Article published 10.1186/s12885-016-2917-6

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us